Home

Balaxi Pharmaceuticals Ltd Quarterly Result

Image

Balaxi Pharmaceuticals Ltd

NSE: BALAXI

Net Profit - Last Quarter

₹ 5.36 Cr.

Last updated on: Feb 23, 2025

Balaxi Pharmaceuticals Ltd Quarterly Results Key Highlights

  • The revenue of Balaxi Pharmaceuticals Ltd for the Dec '24 is ₹ 77.23 crore as compare to the Sep '24 revenue of ₹ 73.27 crore.
  • This represent the growth of 5.4%a1# The ebitda of Balaxi Pharmaceuticals Ltd for the Dec '24 is ₹ 7.93 crore as compare to the Sep '24 ebitda of ₹ 6.48 crore.
  • This represent the growth of 22.38%a1# The net profit of Balaxi Pharmaceuticals Ltd for the Dec '24 is ₹ 5.36 crore as compare to the Sep '24 net profit of ₹ 4.59 crore.
  • This represent the growth of 16.78%a1#.

Balaxi Pharmaceuticals Ltd Quarterly Results Analysis

Market Price of Balaxi Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Balaxi Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 202556.68
20 Feb 202555.77
19 Feb 202553.94
18 Feb 202552.18
17 Feb 202555.87
14 Feb 202560.16
13 Feb 202560.86
12 Feb 202566.08
11 Feb 202565.11
10 Feb 202568

Historical Revenue of Balaxi Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Balaxi Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Balaxi Pharmaceuticals Ltd

No data available

* All values are in crore

Balaxi Pharmaceuticals Ltd News Hub

Balaxi Pharmaceuticals reports consolidated net profit of Rs 6.48 crore in the June 2024 quarter

Net profit of Balaxi Pharmaceuticals reported to Rs 6.48 crore in the quarter ended June 2024 as aga

Read more

02 Aug 24

Balaxi Pharmaceuticals to conduct AGM

Balaxi Pharmaceuticals announced that the 81st Annual General Meeting(AGM) of the company will be he

Read more

01 Aug 24

Balaxi Pharmaceuticals consolidated net profit declines 68.19% in the September 2024 quarter

Net profit of Balaxi Pharmaceuticals declined 68.19% to Rs 4.59 crore in the quarter ended September

Read more

05 Nov 24

Balaxi Pharmaceuticals announces board meeting date

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November 20

Read more

30 Oct 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Balaxi Pharmaceuticals Ltd

What key financial metrics are included in Balaxi Pharmaceuticals Ltd's quarterly results?

Key financial metrics in Balaxi Pharmaceuticals Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Balaxi Pharmaceuticals Ltd announce its quarterly results?

Balaxi Pharmaceuticals Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Balaxi Pharmaceuticals Ltd's quarterly performance impact its stock price?

Balaxi Pharmaceuticals Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Balaxi Pharmaceuticals Ltd's quarterly results on dividends?

The impact of Balaxi Pharmaceuticals Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Balaxi Pharmaceuticals Ltd's quarterly results?

Yes, Balaxi Pharmaceuticals Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions